Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Foghorn Therapeutics Inc. (FHTX)

Simbol lan logo merek Foghorn Therapeutics, Inc. (FHTX)

Foghorn Therapeutics (FHTX) operates in the non-cyclical blood cancer sector, demonstrating resilience to recessions. A unique gene modification method allows the company to claim premium pricing for its drugs. Experienced management maintains investor confidence through partnerships with industry behemoths. The quarterly EPS growth on this chart clearly illustrates profit dynamics, where the value of 420.50 expresses the metric level.

foghorntx.com (FHTX) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan saka 04.07.2022 nganti 15.11.2026

Rincian analitis perusahaan Foghorn Therapeutics

- nilai pasar lan prakiraan target analis:
Analisis fundamental perusahaan:foghorntx.com - FHTX
Produk asil prodhuksi Foghorn Therapeutics

The investment attractiveness of Foghorn Therapeutics (FHTX) is determined by the balance between high R&D expenditures and the potential capitalization of Gene Traffic patents. Quarterly EPS growth measures the change in net income per share, reflecting operational efficiency and the pace of business scaling. By analyzing the quarterly EPS dynamics profile on the GURU.Markets platform, an investor assesses the company's ability to navigate the stringent FDA regulatory filter. A positive trend confirms capital resilience amidst costly clinical trials. This indicator serves as a key marker of the biotech startup's fundamental viability.

Karo sapa Foghorn Therapeutics saingan

tgtherapeutics.com (TGTX) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Arcellx Therapeutics (ACLX)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Disc Medicine Inc|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Syndax Pharmaceuticals SNDX|Wutah bathi EPS kuartalan KURA|ADC Therapeutics SA - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan vorbio.com VOR|NKTX: Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|COEP - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Actinium Pharmaceuticals, Inc. (ATNM) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|ESLA (Estrella Immunopharma) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|CASI - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Marker Bio|Wutah bathi EPS kuartalan IN8bio, Inc.|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Eterna Therapeutics Inc (ERNA)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan gtbiopharma.com|Wutah bathi EPS kuartalan APTO (Aptose Biosciences)|Wutah bathi EPS kuartalan Bio-Path BPTH|MEI Pharma Inc - Wutah bathi EPS kuartalan|VINC (Vincerx Pharma Inc.) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan